Association of clinical and epidemiological characteristics with COVID-19 BNT162b2 mRNA vaccine short-term adverse reactions in healthcare workers

References

• Ball P. The lightning-fast quest for COVID vaccines - and what it means for other diseases. Nature. 2021;589(7840):16–18. doi:10.1038/d41586-020-03626-1.
   PubMed Web of Science ®Google Scholar
• Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586(7830):516–27. doi:10.1038/s41586-020-2798-3.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–15. doi:10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Hernán MA, Lipsitch M, Reis B, Balicer RD, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412–23. doi:10.1056/NEJMoa2101765.
   PubMed Web of Science ®Google Scholar
• Chapin-Bardales J, Gee J, Myers T. Reactogenicity following receipt of mRNA-based COVID-19 vaccines. JAMA - J Am Med Assoc. 2021;325(21):2201–02. doi:10.1001/jama.2021.5374.
   PubMed Web of Science ®Google Scholar
• Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of pfizer-BioNTech COVID-19 vaccine. JAMA - J Am Med Assoc. 2021;325(8):780–81. doi:10.1001/jama.2021.0600.
   PubMed Web of Science ®Google Scholar
• Lee YW, Lim SY, Lee J-H, Lim JS, Kim M, Kwon S, Joo J, Kwak SH, Kim EO, Jung J, et al. Adverse reactions of the second dose of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in Korea. J Korean Med Sci. 2021;36(21):e153. doi:10.3346/jkms.2021.36.e153.
   PubMed Web of Science ®Google Scholar
• Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021;10(7):1428. doi:10.3390/jcm10071428.
   PubMed Web of Science ®Google Scholar
• Terpos E, Trougakos IP, Apostolakou F, Charitaki I, Sklirou AD, Mavrianou N, Papanagnou E-D, Liacos C-I, Gumeni S, Rentziou G, et al. Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine. Am J Hematol. 2021;96(7) E257-E259 doi: 10.1002/ajh.26185.
   Web of Science ®Google Scholar
• Michos A, Tatsi E-B, Filippatos F, Dellis C, Koukou D, Efthymiou V, Kastrinelli E, Mantzou A, Syriopoulou V. Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162b2 vaccine. Vaccine. 2021 S0264-410X(21)00960-9;39(40):5963–67. doi:10.1016/j.vaccine.2021.07.067.
   PubMed Web of Science ®Google Scholar
• Gee J, Marquez P, Su J, Calvert GM, Liu R, Myers T, Nair N, Martin S, Clark T,  Markowitz L, et al. First month of COVID-19 vaccine safety monitoring — United States, December 14, 2020–January 13, 2021. MMWR Surveill Summ. 2021;70(8):283–88. doi:10.15585/mmwr.mm7008e3.
   Google Scholar
• Kim SH, Wi YM, Yun SY, Ryu JS, Shin JM, Lee EH, Seo KH,  Lee SH, Peck KR. Adverse events in healthcare workers after the first dose of Chadox1 Ncov-19 or Bnt162b2 mRNA Covid-19 vaccination: a single center experience. J Korean Med Sci. 2021;36(14):e107. doi:10.3346/jkms.2021.36.e107.
   Web of Science ®Google Scholar
• Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, Sudre CH, Nguyen LH, Drew DA, Merino J, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939–49. doi:10.1016/S1473-3099(21)00224-3.
   PubMed Web of Science ®Google Scholar
• Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernandez J, Prati D, Baselli G, Asselta R, et al. Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020;383(16):1522–34. doi:10.1056/NEJMoa2020283.
   PubMed Web of Science ®Google Scholar
• Ray JG, Schull MJ, Vermeulen MJ, Park AL, Association Between ABO and Rh Blood Groups and SARS-CoV-2. Infection or severe COVID-19 Illness : a population-based cohort study. Ann Intern Med. 2021;174(3):308–15. doi:10.7326/M20-4511.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration (FDA). Fact sheet for healthcare providers administering vaccine: Emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19); 2021. [accessed 2021 June 7]. https://www.fda.gov/media/144413/download
   Google Scholar
• Shemer A, Pras E, Hecht I. Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination. Isr Med Assoc J. 2021;23:143–44.
   PubMed Web of Science ®Google Scholar
• Özütemiz C, Krystosek LA, Church AL, Chauhan A, Ellermann JM, Domingo-Musibay E, Steinberger D. Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncology patients. Radiology. 2021 E296-E300;300(1):E296–E300. doi:10.1148/radiol.2021210275.
   PubMed Web of Science ®Google Scholar
• Fernández-Prada M, Rivero-Calle I, Calvache-González A, Martinón-Torres F. Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021. Eurosurveillance. 2021;26(10):1–5. doi:10.2807/1560-7917.ES.2021.26.10.2100193.
   Web of Science ®Google Scholar
• Singh B, Kaur P, Kumar V, Maroules M. COVID-19 vaccine induced axillary and pectoral lymphadenopathy on PET scan. Radiol Case Rep. 2021;16(7):1819–21. doi:10.1016/j.radcr.2021.04.053.
   PubMedGoogle Scholar
• Buntz B Tinnitus reports grow amid COVID-19 vaccinations - drug discovery and development. Published 2021. [accessed 2021 August 13]. https://www.drugdiscoverytrends.com/tinnitus-reports-grow-amid-covid-19-vaccinations/
   Google Scholar
• Parrino D, Frosolini A, Gallo C, De Siati RD, Spinato G, de Filippis C. Tinnitus following COVID-19 vaccination: report of three cases. Int J Audiol. 2021;1–4. doi:10.1080/14992027.2021.1931969.
   Web of Science ®Google Scholar
• Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, Broder KR, Gee J, Weintraub E, Shimabukuro T, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices — United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(27):977–82. doi:10.15585/mmwr.mm7027e2.
   PubMed Web of Science ®Google Scholar
• Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, Loran D, Hrncir D, Herring K, Platzer M, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021;e212833. doi:10.1001/jamacardio.2021.2833.
   Google Scholar
• Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, Mantovani R, Varrenti M, Pedrotti P, Conca C, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis multicenter Lombardy registry. Circulation. 2018;138(11):1088–99. doi:10.1161/CIRCULATIONAHA.118.035319.
   PubMed Web of Science ®Google Scholar